| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/30/1992 | CA2071854A1 Method for the production of catalytic rna in bacteria |
| 04/30/1992 | CA2054302A1 Monoclonal antibody-containing agent |
| 04/30/1992 | CA2054149A1 Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals |
| 04/29/1992 | EP0483115A2 Regulatory region for heterologous gene expression in yeast |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0482879A2 Protease from Bacillus licheniformis |
| 04/29/1992 | EP0482844A2 GL-7ACA acylase |
| 04/29/1992 | EP0482714A1 Increased production of thermus aquaticus DNA polymerase in E. coli |
| 04/29/1992 | EP0482713A2 Reaction vessels |
| 04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
| 04/29/1992 | EP0482544A2 Spheroplast fusions of phaffia rhodozyma cells |
| 04/29/1992 | EP0482426A1 Novel circular plasmids derived from the genus rhodococcus |
| 04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
| 04/29/1992 | EP0482125A1 Aerosol beam microinjection |
| 04/29/1992 | EP0482124A1 Somatotropin analogs. |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482077A1 Method for producing novel polyester biopolymers |
| 04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 04/29/1992 | EP0482053A1 Dna constructs, cells and plants derived therefrom |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | EP0481999A1 Preventing interference with affinity capture schemes. |
| 04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5109124 Nucleic acid probe linked to a label having a terminal cysteine |
| 04/28/1992 | US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5109112 FK-506 cytosolic binding protein |
| 04/28/1992 | US5108925 Using decarbonxylase enzyme gene |
| 04/28/1992 | US5108922 Wound healing agent, ability to induce the formation of bone and catilage; |
| 04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
| 04/28/1992 | US5108919 Dna sequences encoding yeast ubiquitin hydrolase |
| 04/28/1992 | US5108918 Screening dna of host capable of producing metabolite using probes obtained from the rna or dna of bacteria or fungi lacking the ability to product the metabolite, transforming the host and cloning |
| 04/28/1992 | US5108917 Process for the preparation of ibuprofen |
| 04/28/1992 | US5108911 Process for preparing bovine interleukin-Iβ |
| 04/28/1992 | US5108909 Expression of TPA in mammalian cells |
| 04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
| 04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
| 04/28/1992 | US5108744 Vaccines for Haemophilus influenzae |
| 04/28/1992 | US5108457 Enzymatic peracid bleaching system with modified enzyme |
| 04/28/1992 | CA1299772C Scanning fluorescent detection system |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299508C Human pancreatic elastase i |
| 04/28/1992 | CA1299507C Grf analogs |
| 04/28/1992 | CA1299506C Diagnostic probe for diabetes type i predisposition |
| 04/27/1992 | WO1992007961A1 Specific detection of antibodies to human t-cell leukemia viruses |
| 04/27/1992 | WO1992007955A1 Method for evaluating the adequacy of clinical specimens for hybridization assays and kit for performing the evaluation |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094832A1 Specific detection of antibodies to human t-cell leukemia viruses |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2052827A1 Increased production of thermus aquaticus dna polymerase in e.coli |
| 04/26/1992 | WO1992007873A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | WO1992007582A1 Corynebacteria and related organisms as vaccine vectors |
| 04/26/1992 | CA2094718A1 Corynebacteria and related organisms as vaccine vectors |
| 04/26/1992 | CA2091760A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | CA2046523A1 Lockable valve mechanism for sample pouch |
| 04/25/1992 | CA2054069A1 Expression system |
| 04/24/1992 | WO1992006994A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/24/1992 | WO1992006985A1 Mechanism based inhibitors of dna methyltransferase |
| 04/24/1992 | CA2093672A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/24/1992 | CA2072083A1 Mechanism based inhibitors of dna methyltransferase |
| 04/24/1992 | CA2044781A1 Spheroplast fusions of phaffia rhodozyma cells |
| 04/23/1992 | WO1992006693A1 Dna construct for providing rna therapy |
| 04/23/1992 | DE4033120A1 Genomic DNA fragment encoding antibody variable region prodn. - by attaching primers to hybridoma DNA then subjecting to polymerase chain reaction, for constructing genes encoding chimeric antibodies |
| 04/23/1992 | DE4030264A1 Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren Process for the preparation of purified glycolipids by membrane separation process |
| 04/23/1992 | CA2094608A1 Dna construct for providing rna therapy |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481963A2 Microorganisms for degrading toxic waste materials |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481704A1 Amplification of midivariant DNA templates |
| 04/22/1992 | EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression |
| 04/22/1992 | EP0481536A1 Synthetic genes for human interleukin-1-alpha |
| 04/22/1992 | EP0481504A1 Recombinant transglutaminase |
| 04/22/1992 | EP0481502A2 Process for the production of chimaeric antibodies |
| 04/22/1992 | EP0481215A1 Method for the detection of an HIV-1 genome by a two-step PCR method and oligonucleotide used in the same |
| 04/22/1992 | EP0481072A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481069A1 Method for reducing carryover contamination in an amplification procedure |
| 04/22/1992 | EP0481008A1 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0480971A1 A method for introducing molecules, particularly genetic material, into plant cells |
| 04/22/1992 | EP0480923A1 Method of producing proteins with fviii activity and/or fviii derivatives. |
| 04/22/1992 | EP0472599A4 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 04/22/1992 | EP0467883A4 Method of physically mapping genetic material |
| 04/22/1992 | EP0245291B1 Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 04/22/1992 | EP0190362B1 Process for treating cells |
| 04/22/1992 | EP0144408B2 Dna sequence |
| 04/22/1992 | CN1060499A Human zona pellucida protein zp3 |
| 04/22/1992 | CN1060498A Recombinant expression vectors capable of expressing immunogenic malarial antigens on surface of salmonella vaccine strains |
| 04/21/1992 | US5107065 Genetic engineering |
| 04/21/1992 | US5106966 Adding a polymer gel to a water-immiscible solvent and agitating with an aqueous brine solution; kits |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106748 Isolated DNA molecule with sequence encoding bone morphogenic protein which induces formation of cartilage and/or bone |
| 04/21/1992 | US5106747 Reduction in waste products and concomitant synthesis of amino acids |
| 04/21/1992 | US5106746 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
| 04/21/1992 | US5106741 Tissue plasminogen activator (TPA) analogs |
| 04/21/1992 | US5106739 High levels of expression of coding |